Table 1 Association of circulating lipids with biliary tract cancer risk according to different methods
From: Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians
| Â | HDL | LDL | CHL | TRG |
|---|---|---|---|---|
Inverse variance weighted | ||||
  OR (95%CI) | 1.38 (0.98, 1.94) | 1.46 (0.96, 2.23) | 1.34 (0.83, 2.16) | 0.48 (0.31, 0.74) |
  Q statistics (P value) | 24.6 (0.431) | 20.6 (0.298) | 25.5 (0.274) | 5.9 (0.662) |
MR-egger | ||||
  OR (95%CI) | 2.10 (0.99, 4.46) | 1.36 (0.70, 2.63) | 1.50 (0.50, 4.50) | 0.46 (0.19, 1.12) |
  Q statistics (P value) | 23.3 (0.444) | 20.5 (0.247) | 25.5 (0.228) | 5.9 (0.556) |
  Intercept (P value) | -0.048 (0.274) | 0.009 (0.804) | -0.009 (0.842) | 0.004 (0.946) |
Weighted median | ||||
  OR (95%CI) | 1.55 (0.94, 2.58) | 1.74 (1.02, 2.97) | 2.16 (1.15, 4.07) | 0.46 (0.27, 0.76) |
Weighted mode | ||||
  OR (95%CI) | 1.73 (0.99, 3.02) | 1.75 (0.97, 3.14) | 2.51 (0.98, 6.40) | 0.48 (0.27, 0.83) |